Skip to main content
Smart Investors Daily
The Procter & Gamble Company logo

NYSE · PG

The Procter & Gamble Company

Consumer Defensive · Household & Personal Products

$144.26

Up+$0.29 (+0.20%)

Updated Aug 15, 2026, 1:23 AM

SID Score

6.9/10

Composite research score

Smart Money

56/100

Neutral

Market cap
328.87B
P/E ratio
20.46
Dividend yield
2.90%
52-week range
$137.62 – $167.25
Volume
7.49M
Avg. volume
8.54M

Price performance

PG price history

1M range · 20 trading sessions · Daily adjusted prices

PG closed at $144.26 after 20 trading sessions, down 3.81% for the selected period.

Last close
$144.26
Period change
-3.81%
Period low
$143.96
Period high
$149.98
Daily close
View OHLC price history
PG OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 13, 2026$144.59$145.80$143.995$144.267.49M
Aug 12, 2026$144.05$144.94$143.79$144.087.2M
Aug 11, 2026$145.41$145.71$143.93$145.217.94M
Aug 10, 2026$144.73$146.46$144.15$146.447.39M
Aug 7, 2026$144.90$146.00$143.88$145.797.57M
Aug 6, 2026$147.82$148.50$145.45$146.978.77M
Aug 5, 2026$147.845$147.845$144.66$146.809.75M
Aug 4, 2026$144.04$148.25$143.79$148.017.36M
Aug 3, 2026$145.85$147.15$144.26$144.978.94M
Jul 31, 2026$143.51$144.70$141.46$144.499.15M
Jul 30, 2026$143.76$144.45$142.25$143.969.57M
Jul 29, 2026$141.38$146.38$140.20$146.1014.62M
Jul 28, 2026$151.50$153.68$148.52$148.8812.85M
Jul 27, 2026$147.85$150.245$147.85$148.637.3M
Jul 24, 2026$146.45$147.99$145.40$147.416.62M
Jul 23, 2026$146.14$147.61$145.59$146.976.5M
Jul 22, 2026$149.50$150.46$148.815$149.135.37M
Jul 21, 2026$147.86$148.41$146.88$148.107.03M
Jul 20, 2026$149.56$150.10$148.43$149.135.79M
Jul 17, 2026$152.86$154.32$149.31$149.988.92M

Latest PG news

The latest Smart Investors Daily articles mentioning PG.

PG research

Overview

Company profile and research snapshot.

Company profile

Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of nearly $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$167.33
Implied upside
Analysts
15
PG recent ratings
DateFirmRatingTarget
Aug 7, 2026Argus ResearchHold
Jul 30, 2026CitigroupBuy
Jul 30, 2026HSBCHold
Jul 21, 2026BarclaysEqual-Weight
Jul 16, 2026JP MorganOverweight
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 14, 2026

Jim Cramer Said Kimberly-Clark Corporation (NYSE:KMB) + Kenvue Could Take On P&G – But Is He Right?

Personal care products provider Kimberly-Clark Corporation (NYSE:KMB)’s shares are down by 17% over the past year and are up by 9% year-to-date. It is currently undergoing a major transformation through acquiring Kenvue. Cramer has discussed Kimberly-Clark Corporation (NYSE:KMB)’s acquisition several times and linked its performance with consumer goods giant Procter & Gamble. In his morning […]

AI research layers

Interpretive context generated from the platform’s current data sources.

Procter & Gamble Stock Performance

Procter & Gamble shares traded at $144.26, reflecting a modest daily gain of 0.09%, per SID market data. Over the trailing one-month period, the stock declined 1.37%, while the three-month return was essentially flat at 0.12%. The one-year performance showed a loss of 1.97%, underperforming the broader consumer defensive sector. Technically, PG trades below both its 50-day moving average of $147.69 and its 200-day moving average of $149.60, indicating sustained downward pressure according to Massive/Polygon data. The 14-day relative strength index stands at 41.2, approaching oversold territory but not yet triggering a contrarian buy signal. The stock's beta of 0.382 confirms its historically low volatility relative to the broader market. Average daily trading volume registered at approximately 8.54 million shares, supporting adequate liquidity. The current market capitalization stands at approximately $328.9 billion.

Procter & Gamble Valuation Analysis

Procter & Gamble currently trades at a price-to-earnings ratio of 20.46, which remains moderate for a large-cap consumer defensive name, per SID market data. However, the PEG ratio of 3.90 suggests the stock is richly valued relative to its expected earnings growth trajectory, indicating that investors are paying a significant premium for each unit of anticipated growth. The price-to-book ratio stands at 6.44, reflecting the substantial intangible asset value embedded in PG's portfolio of globally recognized brands, according to SEC filings. The company offers a dividend yield of 2.97%, providing income-oriented investors with a return that exceeds the broader market average. Within the consumer defensive sector, PG's valuation metrics reflect its status as a blue-chip compounder, though the elevated PEG ratio raises questions about whether current growth rates justify the premium. The $328.9 billion market capitalization underscores PG's positioning among the largest consumer staples companies globally.

Smart Money Activity for PG

Procter & Gamble's composite smart money score stands at 56 out of 100, reflecting a neutral overall signal, per SID market data. Institutional ownership scored a perfect 25 out of 25, indicating robust conviction among large asset managers and fund complexes according to 13F institutional filings. Insider activity scored 12.5 out of 25, with SEC Form 4 filings revealing 6 insider transactions over the past 90 days — all of which were purchases, with zero insider sales recorded during the period. This unanimously bullish insider buying pattern suggests that company executives and directors view current price levels as attractive. Dark pool activity scored 8.9 out of 25, indicating relatively limited off-exchange institutional accumulation. Congressional trading activity registered at 9.6 out of 25, reflecting modest engagement from lawmakers. The divergence between strong institutional ownership and moderate dark pool activity suggests that while long-term holders remain committed, new large-scale positioning has been subdued in recent months.

Procter & Gamble Earnings Outlook

Procter & Gamble has demonstrated consistent earnings execution in its most recent reporting periods, according to company earnings reports. In the quarter reported on July 29, 2026, the company posted earnings per share of $1.43, exceeding the consensus estimate of $1.42 by $0.01. The prior quarter, reported on April 24, 2026, showed stronger outperformance, with actual EPS of $1.59 surpassing analyst expectations of $1.56 by $0.03. Looking ahead, analyst estimates project EPS of $1.42 for the upcoming quarter ending July 28, 2026, and $1.57 for the quarter ending April 23, 2026, per consensus data. The sequential decline in estimates from $1.57 to $1.42 reflects anticipated seasonal patterns in PG's product portfolio. The company's track record of modest but reliable positive earnings surprises reinforces its reputation as a steady performer, though the magnitude of recent beats has remained narrow, limiting potential upside catalysts from earnings alone.

Wall Street Analyst Ratings for PG

Wall Street sentiment on Procter & Gamble has shifted notably in recent weeks, with two prominent firms downgrading the stock, per Wall Street analyst reports. On August 7, 2026, Argus Research downgraded PG from Buy to Hold, while HSBC similarly moved from Buy to Hold on July 30, 2026. These downgrades contrast with continued bullish positioning from Citigroup, which reiterated its Buy rating on July 30, and JP Morgan, which maintained its Overweight rating on July 16, according to SID consensus data. Barclays maintained its Equal-Weight stance on July 21, 2026, reflecting a neutral outlook. The resulting consensus presents a mixed picture, with two firms at Buy or equivalent, one at Equal-Weight, and two at Hold. The clustering of rating changes within a three-week window suggests a fundamental reassessment among analysts, potentially driven by concerns about growth sustainability at current valuation levels. No analyst issued price target upgrades during the period reviewed.